Please login to the form below

Not currently logged in

David Paragamian joins Razorfish Health

He becomes managing director of the Publicis Health agency

Razorfish David ParagamianNew York healthcare agency Razorfish Health has appointed David Paragamian as its managing director.

In his new role, Paragamian will be responsible for overseeing the Publicis Health agency's North America business, including its New York and Philadelphia offices.

Publicis Health group president Matt McNally said: “Dave's deep experience on both the client and agency sides of healthcare communications make him the perfect leader to take Razorfish Health to the next level.”

Paragamian has held a number of senior leadership roles for industry and agency companies, including Johnson & Johnson and Roche, most recently having served as president of ApotheCom.

Prior to this, he was Havas Healthcare's partner and chief executive officer for its Latin America business, and president of global healthcare and advertising communications network Euro RSCG Life.

Paragamian said: “Razorfish Health's positioning as a unique health and wellness agency with the deepest digital roots, strong analytics and outstanding creative makes us a unique full-service partner to drive our clients' brands now and into the future.

“I'm delighted to join the Publicis Health family.”

6th July 2016

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...